Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China flag China · Delayed Price · Currency is CNY
26.92
+0.88 (3.38%)
Aug 29, 2025, 2:45 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202008 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2008 - 2019
Active Pharmaceutical Ingredient
259.90M
Log In
Log In
Log In
Log In
Upgrade
Active Pharmaceutical Ingredient Growth
114.12%
Log In
Log In
Log In
Log In
Upgrade
Preparation
247.13M
Log In
Log In
Log In
Log In
Upgrade
Preparation Growth
19.02%
Log In
Log In
Log In
Log In
Upgrade
Solid
26.76M
Log In
Log In
Log In
Log In
Upgrade
Solid Growth
-36.86%
Log In
Log In
Log In
Log In
Upgrade
Client Peptide
6.18M
Log In
Log In
Log In
Log In
Upgrade
Client Peptide Growth
41.40%
Log In
Log In
Log In
Log In
Upgrade
Consumer Goods and Others
5.93M
Log In
Log In
Log In
Log In
Upgrade
Consumer Goods and Others Growth
-16.50%
Log In
Log In
Log In
Log In
Upgrade
Equipment
1.31M
Log In
Log In
Log In
Log In
Upgrade
Equipment Growth
386.07%
Log In
Log In
Log In
Log In
Upgrade
Other
43.00M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-10.89%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202008 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2008 - 2019
Foreign
325.18M
Log In
Log In
Log In
Log In
Upgrade
Foreign Growth
189.79%
Log In
Log In
Log In
Log In
Upgrade
China
265.02M
Log In
Log In
Log In
Log In
Upgrade
China Growth
-16.97%
Log In
Log In
Log In
Log In
Upgrade